✦ LIBER ✦

Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy

✍ Scribed by Rossi, Valentina; Nolè, Franco; Redana, Stefania; Adamoli, Laura; Martinello, Rossella; Aurilio, Gaetano; Verri, Elena; Sapino, Anna; Viale, Giuseppe; Aglietta, Massimo; Montemurro, Filippo

Book ID: 121494248
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 479 KB
Volume: 23
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2013.10.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retrospective Evaluation of Clinical Out

Retrospective Evaluation of Clinical Outcomes in Patients with HER2-Positive Advanced Breast Cancer Progressing on Trastuzumab-Based Therapy in the Pre-Lapatinib Era

✍ Filippo Montemurro; Stefania Redana; Giuseppe Viale; Giuseppina Sanna; Michela D 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 123 KB

Phase Ib Study of Buparlisib plus Trastu

Phase Ib Study of Buparlisib plus Trastuzumab in Patients with HER2-Positive Advanced or Metastatic Breast Cancer That Has Progressed on Trastuzumab-Based Therapy

✍ Saura, C.; Bendell, J.; Jerusalem, G.; Su, S.; Ru, Q.; De Buck, S.; Mills, D.; R 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 898 KB

Clinical outcomes in patients who receiv

Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology

✍ Kaplan, Muhammet Ali; Isikdogan, Abdurrahman; Koca, Doğan; Kucukoner, Mehmet; Gu 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 245 KB